This is sure to have attracted some attention.
Neuren made EP Vantage’s weekly top market movers list, which also provides a global round up of key events driving biotech/pharma company valuations.
Neuren came in at fourth position and was one of only two non-US companies to make the list. Of the market caps given for the 15 companies, Neuren has the lowest by a significant margin.
http://www.epvantage.com/Universal/View.aspx?type=Story&id=542307§ionID=&isEPVantage=yes
Market mover
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$16.57 |
Change
2.170(15.1%) |
Mkt cap ! $2.117B | |||
| Open | High | Low | Value | Volume |
| $14.85 | $16.67 | $14.60 | $24.77M | 1.544M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1500 | $16.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.57 | 1717 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |